|
EXOSC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.317000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.624400E-01 |
| Normal-vs-Stage2 |
4.645600E-01 |
| Normal-vs-Stage3 |
1.280950E-01 |
| Normal-vs-Stage4 |
2.619800E-02 |
| Stage1-vs-Stage2 |
1.957040E-01 |
| Stage1-vs-Stage3 |
3.528100E-02 |
| Stage1-vs-Stage4 |
2.500700E-03 |
| Stage2-vs-Stage3 |
6.656400E-01 |
| Stage2-vs-Stage4 |
1.012610E-01 |
| Stage3-vs-Stage4 |
1.187440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.163000E-01 |
| Normal-vs-AfricanAmerican |
7.000800E-01 |
| Normal-vs-Asian |
8.541400E-01 |
| Caucasian-vs-AfricanAmerican |
8.108600E-01 |
| Caucasian-vs-Asian |
6.858200E-01 |
| AfricanAmerican-vs-Asian |
7.420000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.151800E-01 |
| Normal-vs-Female |
7.226300E-02 |
| Male-vs-Female |
5.888000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.427000E-01 |
| Normal-vs-Extreme_Weight |
8.425000E-01 |
| Normal-vs-Obese |
1.092580E-01 |
| Normal-vs-Extreme_Obese |
2.764300E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.404600E-01 |
| Normal_Weight-vs-Obese |
4.832800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.182500E-03 |
| Extreme_Weight-vs-Obese |
8.214400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.111700E-02 |
| Obese-vs-Extreme_Obese |
5.556500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.738560E-01 |
| Normal-vs-Age(41-60Yrs) |
7.852400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.733200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.364600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.498400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.684500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.234000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.511770E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.114000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.170200E-01 |
| Normal-VS-Type2 PRCC |
8.211000E-01 |
| Normal-VS-KIRP CIMP |
3.297700E-02 |
| Normal-VS-Unclassified PRCC |
9.383000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.417800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.437800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.298800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.763200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.246200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.379200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.483400E-01 |
| Normal-vs-N1 |
2.010200E-02 |
| Normal-vs-N2 |
7.056600E-01 |
| N0-vs-N1 |
1.203770E-02 |
| N0-vs-N2 |
4.438200E-01 |
| N1-vs-N2 |
4.997200E-01 |
|
|
